Geron Corp. (GERN)
1.695
+0.06
(+3.99%)
USD |
NASDAQ |
Feb 13, 14:13
Geron Free Cash Flow : -132.68M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Plus Therapeutics, Inc. | -15.78M |
| SELLAS Life Sciences Group, Inc. | -30.62M |
| Rezolute, Inc. | -70.49M |
| GT Biopharma, Inc. | -11.36M |
| Jaguar Health, Inc. | -26.29M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -13.58M |
| Cash from Investing (Quarterly) | 13.35M |
| Cash from Financing (Quarterly) | 0.542M |
| Free Cash Flow Per Share (Quarterly) | -0.0202 |
| Free Cash Flow to Equity (Quarterly) | -14.92M |
| Free Cash Flow to Firm (Quarterly) | -4.843M |
| Free Cash Flow Yield | -11.76% |